site stats

Draxxin active ingredient

WebFeb 28, 2024 · DRAXXIN Injectable Solution is a ready-to-use sterile parenteral preparation containing tulathromycin, a semi-synthetic macrolide antibiotic of the subclass triamilide. … WebDRAXXIN contains the active ingredient tulathromycin, the first of a subclass of macrolide, the triamilides, discovered and developed by Zoetis for use in livestock. DRAXXIN is a highly effective, single-dose antimicrobial medication indicated for treatment of BRD, and control of respiratory disease in cattle at high risk of

Draxxin KP - Zoetis Inc.: Veterinary Package Insert

WebActive Ingredient. tulathromycin (25 mg/mL) $91.89 ($0.92/mL) Discounts calculated in your cart and checkout. Get 5% off qualifying animal health products when you spend $3,000-$4,999. ... DRAXXIN® 25 Injectable Solution offers the same proven performance of Draxxin, in a lower concentration formulated for small pigs. ... WebJun 23, 2024 · ACTIVE INGREDIENTS: Each mL of DRAXXIN KP contains 100 mg of tulathromycin as a free base and 120 mg ketoprofen as a free acid in a 50% propylene … tambar springs post office https://joolesptyltd.net

Draxxin® KP, 50 mL FBN

WebACTIVE INGREDIENTS: Each mL of DRAXXIN KP contains 100 mg of tulathromycin as a free base and 120 mg ketoprofen as a free acid in a 50% propylene glycol vehicle. INACTIVE INGREDIENTS: monothioglycerol (5 mg/mL), 2-pyrrolidone (70 mg/mL), citric acid (20 mg/mL) and sodium hydroxide/hydrochloric acid added to adjust pH. WebDraxxin ® (tulathromycin) Injectable Solution. Important Safety Information for Cattle: Do not use in female dairy cattle 20 months of age or older. Do not use in calves to be processed for veal. A pre-slaughter withdrawal time has not been determined for pre-ruminating calves. Effects on reproductive performance, pregnancy and lactation have ... WebThis single dose BRD treatment combines the nonsteroidal anti-inflammatory drug (NSAID) ketoprofen with the antibiotic tulathromycin, the active ingredient in DRAXXIN. Product names and label claims for global brands can vary by country. Please refer to your country Zoetis website for exact country details of product names and label claims. tamba twins \u0026 multiple births association

FREEDOM OF INFORMATION SUMMARY - Food and Drug …

Category:Draxxin KP for Animal Use (Canada) - Drugs.com

Tags:Draxxin active ingredient

Draxxin active ingredient

DailyMed - DRAXXIN- tulathromycin injection, solution

WebContact us for more information — 877.608.3877. Draxxin KP (tulathromycin and ketoprofen Injection) injectable antibiotic for cattle contains two ingredients in one shot for fast recovery of BRD. Formulated with the same active ingredient as Draxxin (tularthromycin), with the addition of a non-steroidal anti-inflammatory (NSAID), ketoprofen. WebDraxxin solution for injection contains 100 mg/ml tulathromycin in a propylene glycol/water for injections vehicle and is packaged in 20, 50, 100, 250 and 500 ml vials. ... The following manufacturing steps have been identified as critical: dissolution of the active ingredient, equilibration of the tulathromycin isomers, pH adjustment and ...

Draxxin active ingredient

Did you know?

WebFeb 8, 2024 · DRAXXIN Injectable Solution is a ready-to-use sterile parenteral preparation containing tulathromycin, a semi-synthetic macrolide antibiotic of the subclass triamilide. … WebAug 16, 2024 · Draxxin is a drug used by veterinarians to treat several diseases in cats. The active ingredient in this drug is meloxicam and it belongs to a group of medications …

WebActive Ingredient. tulathromycin (100 mg/mL) ($2.56/mL) Discounts calculated in your cart and checkout. Get 5% off qualifying animal health products when you spend $3,000 … WebFor cattle producers, Draxxin ® KP (tulathromycin and ketoprofen injection) Injectable Solution is a one-shot combination that provides fast-acting control of fever (pyrexia) …

WebDraxxin ® (tulathromycin) Injectable Solution. Important Safety Information for Cattle: Do not use in female dairy cattle 20 months of age or older. Do not use in calves to be … WebContains active ingredient Tulathromycin. Relatively short withdrawal period for both cattle and swine. Single dose provides upto 14 days of treatment/control for Bovine Respiratory Disease; Recommended …

WebDraxxin pharmaceutical active ingredients containing related brand and generic drugs: Active ingredient is the part of the drug or medicine which is biologically active. This …

WebDRAXXIN 25 Injectable Solution is a ready-to-use sterile parenteral preparation containing tulathromycin, a semi-synthetic macrolide antibiotic of the subclass triamilide. ... Active Ingredient/Active Moiety: Ingredient Name Basis of Strength Strength; TULATHROMYCIN (UNII: Q839I13422) (TULATHROMYCIN - UNII:Q839I13422) TULATHROMYCIN: 25 mg … tamba twins and multiple birth associationtamba water containerWebd. Proprietary Name: DRAXXIN Injectable Solution e. Dosage Form: Sterile injectable solution f. How Supplied: 100 mL, 250 mL, and 500 mL glass vials g. How Dispensed: Rx h. Amount of Active Ingredients: 100 mg/mL i. Route of Administration: Subcutaneous (cattle) or intramuscular (swine) injection in the neck j. txa in traumaWebDRAXXIN is now the first-line product-of-choice to treat BRD, offering both superior disease treatment as well as outstanding efficacy for the control of BRD in cattle at high risk of developing the disease. ... Active ingredient(s): Tulathromycin. How is Draxxin sold? tambayan center for children’s rightsWebJun 23, 2024 · ACTIVE INGREDIENTS: Each mL of DRAXXIN KP contains 100 mg of tulathromycin as a free base and 120 mg ketoprofen as a free acid in a 50% propylene glycol vehicle. INACTIVE INGREDIENTS: … txal-50s-whub-wpWebJun 23, 2008 · Draxxin Injectable Solution contains the active ingredient tulathromycin, the first member of a new macrolide class of antimicrobials known as triamilides (semisynthetic derivatives of erythromycin), which have been developed exclusively for use in veterinary medicine. The product is formulated in an aqueous vehicle for intramuscular (IM ... txa in head bleedWebAlthough the active ingredients in EXCEDE and in DRAXXIN are chemically distinct, the targeted patho-gens and approved use of the two products are similar. Previous studies with DRAXXIN were designed so that animals that met re-treatment criteria were eligible to be re-treated 3 days after they received DRAXXIN.2,3,4 It txa in hemorrhagic stroke